PHARMACEUTICAL FORMULATIONS

The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient, a polyethylene glycol having a freezing point of at least about 30 °C, and a crystallisation rate inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing th...

Full description

Saved in:
Bibliographic Details
Main Authors SHAH Sanket Manoj, LATHUILE Audrey Antoinette Renée, NEEFS Thomas Eddy R, PROKOPCOVÁ Hana, KIMPE Kristof Leonard, HOLM René
Format Patent
LanguageEnglish
Spanish
Published 14.09.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient, a polyethylene glycol having a freezing point of at least about 30 °C, and a crystallisation rate inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing these and their use in methods of treatment are also described. La invención se refiere a formulaciones farmacéuticas que comprenden un principio farmacéutico activo, un polietilenglicol que tiene un punto de congelación de al menos aproximadamente 30 ºC y un inhibidor de la tasa de cristalización; también se describen formas farmacéuticas sólidas que comprenden dichas formulaciones farmacéuticas, procesos para prepararlas y su uso en métodos de tratamiento.
Bibliography:Application Number: MX2021010144